Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Depression: underdiagnosed, undertreated, underappreciated.

David V Sheehan

    Managed Care (Langhorne, Pa.)
    |August 6, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    SIBAT-A Computerized Assessment Tool for Suicide Ideation and Behavior: Development and Psychometric Properties.

    Innovations in clinical neuroscience·2022
    Same author

    Pilot Mental Health Survey, Nepal: Lessons Learned for Survey Design and Instrumentation.

    Innovations in clinical neuroscience·2021
    Same author

    THE DEPRESSION INVENTORY DEVELOPMENT SCALE: Assessment of Psychometric Properties Using Classical and Modern Measurement Theory in a CAN-BIND Trial.

    Innovations in clinical neuroscience·2021
    Same author

    Evaluating functional disability in clinical trials of lisdexamfetamine dimesylate in binge eating disorder using the Sheehan Disability Scale.

    International journal of methods in psychiatric research·2020
    Same author

    Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials.

    Innovations in clinical neuroscience·2018
    Same author

    Restoring function in major depressive disorder: A systematic review.

    Journal of affective disorders·2017

    Major depressive disorder (MDD) remains underdiagnosed and undertreated in primary care. Improving MDD treatment requires a collaborative effort from patients, providers, and policymakers.

    Area of Science:

    • Psychiatry and Mental Health
    • Primary Care Medicine
    • Public Health

    Background:

    • Major depressive disorder (MDD) is a prevalent mental health condition with significant public health implications.
    • Current diagnostic and treatment rates for MDD in primary care settings fall short of optimal levels.
    • Despite increased patient help-seeking and antidepressant use, treatment adequacy remains a challenge.

    Discussion:

    • The underdiagnosis and undertreatment of MDD in primary care represent a critical gap in mental healthcare delivery.
    • Factors contributing to inadequate treatment include systemic issues, provider-level challenges, and patient-related barriers.
    • Addressing this requires a multi-faceted approach involving various stakeholders.

    Key Insights:

    • MDD is frequently missed or inadequately managed within primary care settings.

    Related Experiment Videos

  • Rising antidepressant prescription rates do not equate to sufficient treatment outcomes.
  • A coordinated, multi-stakeholder strategy is essential for improving depression care.
  • Outlook:

    • Future efforts must focus on enhancing diagnostic accuracy and treatment effectiveness for MDD in primary care.
    • Interventions should target patients, healthcare providers, insurance payers, employers, and regulatory bodies.
    • Systemic changes are necessary to ensure equitable and adequate mental healthcare for all individuals with depression.